AbbVie Inc. (ABBV) vs Costco Wholesale Corporation (COST)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Founded in 1983, Costco Wholesale Corp operates a global network of membership-only warehouse clubs focused on offering high-quality products and services at consistently low prices. In its latest fiscal year, the company ran approximately 910 warehouses and served more than 80 million members across three geographic segments: Costco U.S., which generated about 73% of total revenue, Costco Canada at 13%, and Costco International at 14%. Costco’s core value proposition—quality merchandise at highly competitive prices—has supported strong membership renewal rates, reaching 93% in the U.S. and Canada and nearly 90% internationally. Roughly 55% of fiscal 2025 revenue came from grocery sales, while general merchandise contributed another 25%.